• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. SOLO SMART STENTLESS HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. SOLO SMART STENTLESS HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number ART25SMT
Device Problem Degraded (1153)
Patient Problem Heart Failure/Congestive Heart Failure (4446)
Event Type  Injury  
Manufacturer Narrative
H3 other text : not explanted, v-in-v procedure.
 
Event Description
Manufacturer was informed of the following event through publication "a case of a transcatheter valve-in-valve implantation using balloon expandable valve for failed solo smart stentless bioprosthetic valve" by tamura h.Et.Al.Reportedly, a patient who had undergone surgical aortic valve replacement with the solo smart stentless bioprosthetic valve 25 mm and mitral valve replacement with mosaic 29 mm 4 years ago, was diagnosed with congestive heart failure.Echocardiography revealed severe aortic regurgitation caused by degraded bioprosthetic valve.As reported, patient required continuous dobutamine administration to maintain hemodynamics.It was decided to perform transcatheter valve-in-valve implantation (viv-tavi) using balloon expandable valve (edwards sapien 3).Since solo smart stentless valve was placed to valsalva sinus at the supra-annular level with continuous sutures, it was planned to anchor tavi valve 4 mm to the left ventricular side from the bottom of the failed stentless valve.Two pigtail catheters were placed at the bottom of the failed stentless valve leaflet to mark the nadir of stentless valve.After viv-tavi, the patient no longer required catecholamine administration and was discharged home one month later.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLO SMART STENTLESS HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA   V5J 5M1
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key18822929
MDR Text Key336733065
Report Number3004478276-2024-00117
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P130011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberART25SMT
Device Catalogue NumberICV1264
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/02/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient SexMale
Patient Weight67 KG
-
-